Drug Profile
Research programme: MEP pathway inhibitors - Ferrer
Alternative Names: GF-011802-00; GF-011806-00Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Ferrer
- Class
- Mechanism of Action Enzyme inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in Spain
- 09 Jan 2009 Preclinical development is ongoing in Spain
- 24 Jan 2006 Preclinical trials in Bacterial infections in Spain (unspecified route)